GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells

被引:127
作者
Ge, GX
Hopkins, DR
Ho, WB
Greenspan, DS
机构
[1] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA
[2] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA
[3] Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA
[4] FibroGen Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1128/MCB.25.14.5846-5858.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
All transforming growth factor beta (TGF-beta) superfamily members are synthesized as precursors with prodomain sequences that are proteolytically removed by subtilisin-like proprotein convertases (SPCs). For most superfamily members, this is believed sufficient for activation. Exceptions are TGF-beta s 1 to 3 and growth differentiation factor 8 (GDF8), also known as myostatin, which form noncovalent, latent complexes with their SPC-cleaved prodomains. Sequence similarities between TGF-beta s 1 to 3, myostatin, and superfamily member GDF11, also known as bone morphogenetic protein 11 (BMP11), prompted us to examine whether GDF11 might be capable of forming a latent complex with its cleaved prodomain. Here we demonstrate that GDF11 forms a noncovalent latent complex with its SPC-cleaved prodomain and that this latent complex is activated via cleavage at a single specific site by members of the developmentally important BMP1/Tolloid family of metalloproteinases. Evidence is provided for a molecular model whereby formation and activation of this complex may play a general role in modulating neural differentiation. In particular, mutant GDF11 prodomains impervious to cleavage by BMP1/Tolloid proteinases are shown to be potent stimulators of neurodifferentiation, with potential for therapeutic applications.
引用
收藏
页码:5846 / 5858
页数:13
相关论文
共 45 条
[1]   Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 [J].
Annes, JP ;
Chen, Y ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL BIOLOGY, 2004, 165 (05) :723-734
[2]   The recombinant proregion of transforming growth factor beta 1 (Latency-associated peptide) inhibits active transforming growth factor beta 1 in transgenic mice [J].
Bottinger, EP ;
Factor, VM ;
Tsang, MLS ;
Weatherbee, JA ;
Kopp, JB ;
Qian, SW ;
Wakefield, LM ;
Roberts, AB ;
Thorgeirsson, SS ;
Sporn, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5877-5882
[3]  
BULLOUGH WS, 1965, CANCER RES, V25, P1683
[4]   Thrombospondin-1 is a major activator of TGF-β1 in vivo [J].
Crawford, SE ;
Stellmach, V ;
Murphy-Ullrich, JE ;
Ribeiro, SMF ;
Lawler, J ;
Hynes, RO ;
Boivin, GP ;
Bouck, N .
CELL, 1998, 93 (07) :1159-1170
[5]   Authentic matrix vesicles contain active metalloproteases (MMP) -: A role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-β [J].
D'Angelo, M ;
Billings, PC ;
Pacifici, M ;
Leboy, PS ;
Kirsch, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :11347-11353
[6]   The family of bone morphogenetic proteins [J].
Ducy, P ;
Karsenty, G .
KIDNEY INTERNATIONAL, 2000, 57 (06) :2207-2214
[7]   A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos [J].
Gamer, LW ;
Wolfman, NM ;
Celeste, AJ ;
Hattersley, G ;
Hewick, R ;
Rosen, V .
DEVELOPMENTAL BIOLOGY, 1999, 208 (01) :222-232
[8]   Biosynthetic processing of the pro-α1(V)pro-α2(V)pro-α3(V) procollagen heterotrimer [J].
Gopalakrishnan, B ;
Wang, WM ;
Greenspan, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) :30904-30912
[9]   REQUIREMENT FOR ACTIVIN-A AND TRANSFORMING GROWTH FACTOR-BETA-1 PRO-REGIONS IN HOMODIMER ASSEMBLY [J].
GRAY, AM ;
MASON, AJ .
SCIENCE, 1990, 247 (4948) :1328-1330
[10]  
Greene L., 1982, ADV CELL NEUROBIOL, V3, P373, DOI DOI 10.1016/B978-0-12-008303-9.50016-5